Iconic Therapeutics Brings Brandon Smith On Board as COO

Xconomy San Francisco — 

Iconic Therapeutics has appointed Brandon Smith chief operating officer. South San Francisco, CA-based Iconic is developing therapies for retinal disease and cancer. Smith comes to Iconic from Hayward, CA-based Impax Laboratories (NASDAQ: IPXL), where he was senior vice president of corporate development and strategy. Before Impax, Smith was an executive director at Amgen (NASDAQ: AMGN), where he worked on biosimiliar business development.